Product Images Guanfacine
View Photos of Packaging, Labels & Appearance
Product Label Images
The following 9 images provide visual information about the product associated with Guanfacine NDC 16714-193 by Northstar Rxllc, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.
This is a description of a medication with the NDC code 16714-190-01. The medication is Guanfacine, Extended-Release Tablets, USP, with a strength of 1mg. The tablets should not be crushed, chewed, or broken before swallowing. Each tablet contains guanfacine hydrochloride, USP, at a strength of 1 mg. The usual dosage and further prescribing information can be found in the package insert. The medication should be stored at 20° to 25° C (68° to 77°F). The medication is manufactured for NorthStar Rx LLC in Memphis, TN, and manufactured by Ohm Laboratories Inc. in New Brunswick, NJ. The product is made in Spain.*
This is a description of the medication Guanfacine. It comes in the form of Extended-Release Tablets, USP and contains 3mg of quanfacine, as guanfacine hydrochloride, USP. The tablets should not be chewed, crushed or broken before swallowing. The usual dosage can be found in the package insert. It comes in a bottle of 100 tablets and should be stored at 20° to 25° C (68° t0 77°F). The medication is manufactured for NorthStar Rx LLC and manufactured by Ohm Laboratories Inc. It is a product of Spain.*
Guanfacine Extended-Release Tablets, USP, is a medication that comes in a bottle of 100 tablets, each containing 4 mg of quanfacine, as guanfacine hydrochloride, USP. The tablets are not to be crushed, chewed or broken before swallowing. The package insert should be consulted for complete prescribing information. The tablets should be stored at a temperature of 20° to 25° C. It is manufactured by Ohm Laboratories Inc., New Brunswick, NJ and is a product of Spain, distributed by NorthStar Rx LLC, Memphis, TN.*
This appears to be a graph showing the percentage of treatment fare for a placebo and the drug SPD503 over a certain number of days. The x-axis appears to show the days of treatment, while the y-axis shows the percentage of successful treatment fare. There is no specific information on what condition or illness this study was testing for.*
* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.